Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study (2014)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.3892/etm.2014.1864
- Subjects: LÍTIO; TRANSTORNO BIPOLAR; DEPRESSÃO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Experimental and Therapeutic Medicine
- ISSN: 1792-0981
- Volume/Número/Paginação/Ano: 8, n. 4, p. 1205-1208, 2014
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
-
ABNT
MACHADO-VIEIRA, Rodrigo et al. Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study. Experimental and Therapeutic Medicine, n. 4, p. 1205-1208, 2014Tradução . . Disponível em: https://doi.org/10.3892/etm.2014.1864. Acesso em: 18 abr. 2024. -
APA
Machado-Vieira, R., Zanetti, M. V., De Sousa, R. T., Soeiro‑De‑Souza, M. G., Moreno, R. A., Busatto, G. F., & Gattaz, W. F. (2014). Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study. Experimental and Therapeutic Medicine, ( 4), 1205-1208. doi:10.3892/etm.2014.1864 -
NLM
Machado-Vieira R, Zanetti MV, De Sousa RT, Soeiro‑De‑Souza MG, Moreno RA, Busatto GF, Gattaz WF. Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study [Internet]. Experimental and Therapeutic Medicine. 2014 ;( 4): 1205-1208.[citado 2024 abr. 18 ] Available from: https://doi.org/10.3892/etm.2014.1864 -
Vancouver
Machado-Vieira R, Zanetti MV, De Sousa RT, Soeiro‑De‑Souza MG, Moreno RA, Busatto GF, Gattaz WF. Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study [Internet]. Experimental and Therapeutic Medicine. 2014 ;( 4): 1205-1208.[citado 2024 abr. 18 ] Available from: https://doi.org/10.3892/etm.2014.1864 - Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
- Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients
- Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
Informações sobre o DOI: 10.3892/etm.2014.1864 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
